SLC5A2 rs4536493: What Your Genotype Means
The rs4536493 variant is a single nucleotide polymorphism located within the SLC5A2 gene, which encodes the SGLT2 protein. Research is currently investigating whether this genetic variation influences clinical outcomes in patients prescribed SGLT2 inhibitor medications.
What each genotype means
Typical SLC5A2 genotype
This genotype represents the most common genetic sequence at this position in the SLC5A2 gene. Research indicates that variations in this gene may influence how patients respond to SGLT2 inhibitor medications, but the specific clinical impact of this genotype remains an area of ongoing study. Please discuss your medication response and treatment goals with your clinician or pharmacist.
This genotype is common across most global populations, though exact frequencies vary by ancestry.
Variant SLC5A2 genotype
Carrying one copy of the G allele at this position has been identified in research exploring factors that may influence clinical outcomes in patients treated with SGLT2 inhibitors. Because the evidence regarding how this specific genotype affects drug efficacy is still emerging, it should not be used to guide clinical decisions. Please consult your healthcare provider or pharmacist regarding your current treatment plan.
This genotype is found at varying frequencies across different ancestral groups, with specific prevalence data often limited in public databases.
Variant SLC5A2 genotype
Carrying two copies of the G allele at this position is a variation that has been studied for its potential association with clinical outcomes in patients receiving SGLT2 inhibitor therapy. Current scientific evidence is not sufficient to determine a definitive clinical effect, and this information should not replace professional medical advice. Always discuss your medication management with your clinician or pharmacist.
This genotype is less common than the A/A genotype and its frequency varies significantly depending on the population studied.
Understanding the SLC5A2 Gene
The SLC5A2 gene provides instructions for creating the sodium-glucose cotransporter 2 (SGLT2) protein. This protein is primarily located in the proximal tubules of the kidneys, where it plays a critical role in reabsorbing glucose from the urine back into the bloodstream. By regulating this process, SGLT2 helps maintain healthy blood glucose levels. Medications known as SGLT2 inhibitors work by blocking this transporter, which encourages the body to excrete excess glucose through urine. Because of this mechanism, SGLT2 inhibitors are frequently used to manage type 2 diabetes and certain heart conditions. Genetic variations within the SLC5A2 gene are of interest to researchers because they may alter the expression, structure, or function of the SGLT2 protein, potentially changing how an individual's body responds to these specific medications.
The Role of rs4536493
The variant rs4536493 is a specific change in the DNA sequence of the SLC5A2 gene. In the field of pharmacogenomics, scientists study such variants to determine if they act as biomarkers for drug efficacy or safety. While some variants in SLC5A2 have been linked to differences in glucose handling or heart failure risk, the evidence regarding rs4536493 specifically is considered moderate. Current research is focused on whether this SNP influences the clinical response to SGLT2 inhibitors, such as changes in HbA1c levels or cardiovascular outcomes. It is important to note that genetic associations are often complex and influenced by many factors, including other genes, lifestyle, and environmental variables. Consequently, findings from one study may not always be replicated in different populations or clinical settings, and the scientific community continues to evaluate the clinical significance of this specific variant.
Interpreting Your Genetic Information
If you have information about your rs4536493 genotype, it is essential to understand that this data does not provide a medical diagnosis or a definitive prediction of how you will respond to any medication. Pharmacogenomic research is an evolving field, and while genetic markers can offer insights into biological variability, they are only one piece of a much larger clinical puzzle. You should never use this information to start, stop, or change the dosage of any prescribed medication. If you are concerned about how a drug like an SGLT2 inhibitor might affect you, or if you are interested in how your genetics might influence your treatment plan, please discuss this with your healthcare provider or a clinical pharmacist. They are best equipped to interpret your genetic results in the context of your overall health history and current treatment goals.
How common is this variant?
Specific population frequency data for rs4536493 is not widely documented in standard public catalogs. Frequency can vary significantly across different ancestral groups, and further large-scale genomic studies are required to establish precise prevalence rates.
Frequently asked questions
What is the SLC5A2 gene?
The SLC5A2 gene encodes the SGLT2 protein, which is responsible for reabsorbing glucose in the kidneys. It is the primary target for SGLT2 inhibitor medications used in diabetes and heart failure treatment.
Can this SNP predict my response to diabetes medication?
While some research suggests that SLC5A2 variants may influence drug response, the evidence is not strong enough to use this SNP as a definitive predictor. Always consult your doctor regarding your medication efficacy.
Should I change my medication based on my genotype?
No. You should never change your medication or dosage based on genetic test results without consulting your healthcare provider. Genetic data is only one factor in clinical decision-making.
Where can I find more information on pharmacogenomics?
You can explore resources like PharmGKB or MedlinePlus Genetics for reliable, evidence-based information on how genes affect drug responses. These sites provide summaries of current scientific understanding.
Sources & further reading
Educational information only, last refreshed 9/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4536493?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29